Clearstead Advisors, LLC Rhythm Pharmaceuticals, Inc. Transaction History
Clearstead Advisors, LLC
- $6.94 Billion
- Q2 2025
A detailed history of Clearstead Advisors, LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 590 shares of RYTM stock, worth $54,268. This represents 0.0% of its overall portfolio holdings.
Number of Shares
590Holding current value
$54,268% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RYTM
# of Institutions
254Shares Held
63.1MCall Options Held
403KPut Options Held
62.8K-
Black Rock Inc. New York, NY6.74MShares$620 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$560 Million6.69% of portfolio
-
Primecap Management CO Pasadena, CA5.79MShares$532 Million0.26% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$516 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$317 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.13B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...